Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93316

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 09, 2023
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

D-0140-2024
Recall number
D-0140-2024
Initiated
November 09, 2023
Classification
Class III
Status
Terminated
Quantity
190 syringes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product Mix-up: Incorrect Product Formulation

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Product Mix-up: Incorrect Product Formulation

Code information

Lot#: 09202023@7, Exp 03/18/2024

Distribution pattern

USA Nationwide